Search Results - Jason Tay
- Showing 1 - 6 results of 6
-
1
-
2
-
3
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary by Ellen Lewis, Nowell Fine, Sylvia McCulloch, Jason Tay, Peter Duggan, Paola Neri, Nizar Bahlis, Victor H. Jimenez-Zepeda
Published in Current Oncology (2024-09-01)Get full text
Article -
4
Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review by Jessie Luo, Nizar J. Bahlis, Denise Chan, Peter Duggan, Victor H. Jimenez-Zepeda, Holly Lee, Sylvia McCulloch, Paola Neri, Jason Tay
Published in Current Oncology (2024-11-01)Get full text
Article -
5
Clinical and Pathological Characteristics of Non-AL Amyloidosis MGRS: A Single-Center Experience Over 10 Years by Chunpeng Nie, Holly Lee, Kim Cheema, Peter Duggan, Sylvia McCulloch, Jason Tay, Paola Neri, Nizar J. Bahlis, Victor H. Jimenez-Zepeda
Published in Canadian Journal of Kidney Health and Disease (2025-02-01)Get full text
Article -
6
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination by Kareem Jamani, Judy MacDonald, Martin Lavoie, Tyler S. Williamson, Christopher B. Brown, Ahsan Chaudhry, Victor H. Jimenez-Zepeda, Peter Duggan, Jason Tay, Douglas Stewart, Andrew Daly, Jan Storek
Published in Blood Advances (2016-12-01)Get full text
Article
